Search


 
Results 51 - 60 of about 88 for "FDA update".

Liraglutide gets new cardiovascular indication | ACP Diabetes ...

The FDA approved a new indication for liraglutide to reduce the risk of myocardial infarction, stroke, and cardiovascular death in adults with type 2 ...

September 8, 2017 | ACP Diabetes Monthly

... intensive hypertension treatment strategies. FDA update. Liraglutide gets new cardiovascular indication. The FDA approved a ...

June 9, 2017 | ACP Diabetes Monthly

... gastrectomy. FDA update. Canagliflozin will receive new boxed warning about amputation risks. Canagliflozin (Invokana ...

April 13, 2018 | ACP Diabetes Monthly

... and diabetes. FDA update. First continuous glucose monitoring system approved to be used with other devices. The system ...

October 13, 2017 | ACP Diabetes Monthly

... soon or too late. FDA update. CGM system approved for use without finger sticks. A continuous glucose monitoring (CGM ...

February 13, 2015 | ACP Diabetes Monthly

... to a new study. FDA update. Glucose monitoring app, weight-loss device, medications approved. The FDA approved an ...

June 10, 2016 | ACP Diabetes Monthly

... and recent polyuria and polydipsia. FDA update. Alert on canagliflozin and amputations. An ongoing clinical trial found an ...

January 8, 2016 | ACP Diabetes Monthly

... 30 kg/m 2 or greater. FDA update. Rosiglitazone REMS ends, new insulin approved. The FDA has determined that the Risk ...

August 8, 2014 | ACP Diabetes Monthly

... meta-analysis found. FDA update. Empagliflozin approved to treat type 2 diabetes. Empagliflozin (Jardiance), a sodium ...

September 11, 2015 | ACP Diabetes Monthly

... myocardial infarction, or stroke). FDA update. Warning on DPP-4 inhibitors and insulin recall. Dipeptidyl peptidase-4 (DPP ...

Result Page: < Previous  1 2 3 4 5 6 7 8 9  Next >